52w high/low | ₹8.55 / ₹1.85 |
P/E ratio | 86 |
Dividend | 0 |
ROE | 2.72 |
ROCE | 4.02 |
Face value | 1 |
Book value | ₹3.2Cr |
Market capital | ₹60.06Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Neocure Therapeutics (NTL) was originally a partnership firm under the name Indocure Therapeutics. It acquired Pam Industries, a sick pharmaceutical company in Dec. '85. In Sep. '87, the company was incorporated as a private limited company by taking over the partnership firm. It became a public limited company in Aug. '88. The promoters are D Krishna Kumar Raju, D Sreerama Raju and D Bharathi.